Siga Technologies (SIGA) Non-Current Deffered Revenue (2011 - 2018)
Siga Technologies (SIGA) posted Non-Current Deffered Revenue of $376.0 million for Q1 2018, little changed on a QoQ basis from $377.6 million in Q4 2017, and little changed year-over-year from $376.2 million in Q1 2017.
Siga Technologies (SIGA) Non-Current Deffered Revenue (2011 - 2018) Analysis & Trends
Siga Technologies' Non-Current Deffered Revenue history runs 8 years deep, the most recent figure standing at $376.0 million for Q1 2018.
- Quarterly Non-Current Deffered Revenue changed 0.05% year-over-year to $376.0 million in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $376.0 million (changed 0.05% YoY) and the FY2017 annual result came in at $377.6 million, up 2.76% from the prior year.
- Non-Current Deffered Revenue was $376.0 million for Q1 2018 at Siga Technologies, roughly flat from $377.6 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $377.6 million in Q4 2017 and bottomed at $81799.0 in Q4 2014.
- A 5-year average of $268.5 million and a median of $271.9 million in 2016 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2014 — Non-Current Deffered Revenue slumped 99.95% — and 2015, when it surged 311955.61%.
- Siga Technologies' Non-Current Deffered Revenue stood at $81799.0 in 2014, then jumped by 311955.61% to $255.3 million in 2015, then jumped by 43.97% to $367.5 million in 2016, then climbed by 2.76% to $377.6 million in 2017, then slipped by 0.43% to $376.0 million in 2018.
- Business Quant data shows SIGA's Non-Current Deffered Revenue at $376.0 million in Q1 2018, $377.6 million in Q4 2017, and $377.4 million in Q3 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 376.03 Mn |
| Dec 31, 2017 | 377.64 Mn |
| Sep 30, 2017 | 377.45 Mn |
| Jun 30, 2017 | 376.48 Mn |
| Mar 31, 2017 | 376.20 Mn |
| Dec 31, 2016 | 367.48 Mn |
| Sep 30, 2016 | 367.12 Mn |
| Jun 30, 2016 | 288.29 Mn |
| Mar 31, 2016 | 255.47 Mn |
| Dec 31, 2015 | 255.26 Mn |
| Sep 30, 2015 | 255.09 Mn |
| Jun 30, 2015 | 233.74 Mn |
| Mar 31, 2015 | 13.53 Mn |
| Dec 31, 2014 | 81,799.00 |
| Jun 30, 2014 | 188.08 Mn |
| Mar 31, 2014 | 187.78 Mn |
| Dec 31, 2013 | 162.22 Mn |
| Sep 30, 2013 | 162.06 Mn |
| Jun 30, 2013 | 119.07 Mn |
| Mar 31, 2013 | 83.51 Mn |